| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Workplace Communication > Colorful Metaphor or Poison Pill? |
|
Useful Advices - Colorful Metaphor or Poison Pill?
Recently, CNN’s early-bird program ruminated that the business world has and is using too many colorful metaphors too often According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product . From its broadcast, one was left with the impression that phrases like; hitting the ground running, watching the bottom l ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ine, and thinking out of the box, are “poison pills” and should be avoided in favor of more explicit terminology. Colorful lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. metaphors aren’t or don’t need to be “poison pills” they can both elaborate and expand an idea while still being concise. here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe In fact, they may add a colorful emotional quality to what otherwise may be a sterile moonscape presentation. True, you don d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ’t want to sound like a mina bird squawking the same clich? or irritating phrases repeatedly but good communicators, rather ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc in conversation or prose, don’t do this anyway. A good communicator will use metaphors to help us remember and prioritize easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi nformation by painting complete pictures with fewer words, rather than droning in our ears like the buzz of a fly or the re nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically citation of the multiplication tables. People for the most part, are not the binary machines (computers) we often sit at, and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ we’re not Joe Fridays wanting, just the facts. We often need and prefer information to be presented in a way that draws pic ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi tures and makes familiar correlations for us. There are those times when cutting to the chase is much simpler, less dramati ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a c, and more preferable but at these times a simple yes or no may often suffice. Good communication, being a high fidelity t dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ransfer of ideas, experiences, and concepts is enhanced by colorful, well timed metaphors. We understand and draw from anal cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ogies so well we often don’t even realize when a metaphor has been used. Metaphors are the tools that enhance and make us tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen etter communicators. Instead of sliding them to the back burner as CNN would suggest, we should instead welcome and invite t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel their usage as an old friend returned. This is only my opinion, but I suggest you push the envelope a bit, get your ducks i ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust n a row, and take a stab in the dark with metaphors. It’s a no brainer to not go over the top the first time you stretch yo y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ur wings, but metaphors can be the piece of the puzzle you are missing in communication, so wake up and smell the coffee, t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de hey are not poison pills that must be avoided as you climb the corporate ladder. I personal use and enjoy metaphors handil elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip y as you may have guessed since every sentence in this piece contains at least one example, 33 in total, including this one tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Using Promotional Products To Grow An Online Community
|